Learn from the leading CMT experts
Meet the international faculty leading the 2026 summit in Bengaluru. Specialists in neurology, genetics, and hereditary neuropathy research, here to advance clinical practice.
Clinicians and researchers behind the two-day agenda
Our faculty spans neurology, genetics, and rehabilitation from leading institutions. Each speaker brings a focused, evidence-based session to the Bengaluru program.
Dr. Arjun Mehta
Professor of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru
Dr. Mehta specializes in hereditary neuropathies and leads the clinical electrophysiology session, with two decades of experience in neuromuscular disorders.
Dr. Elena Rossi
Consultant Geneticist, University College London (UCL) Institute of Neurology
Dr. Rossi's work focuses on molecular classification of Charcot-Marie-Tooth subtypes, translating genetic findings into clinical diagnostic pathways.
Dr. Priya Raghavan
Paediatric Neurologist, Christian Medical College, Vellore
Dr. Raghavan addresses early-onset CMT presentations, guiding residents and fellows through diagnostic challenges in paediatric hereditary neuropathy.
Dr. Kwame Osei
Principal Investigator, Hereditary Neuropathy Research Group, University of Toronto
Dr. Osei examines biomarkers and pathophysiology, presenting recent data on disease progression and potential therapeutic targets.
Prof. Daniel Fischer
Head of Neuromuscular Rehabilitation, University Hospital Zurich
Prof. Fischer leads the multidisciplinary care session, covering orthotic management, physiotherapy, and functional outcomes for CMT patients.
Dr. Rohan Iyer
Research Fellow, Molecular Therapies Lab, Tata Institute of Fundamental Research, Mumbai
Dr. Iyer contributes to the gene-based therapies session, with active research on antisense oligonucleotide approaches for inherited neuropathies.
Dr. Hannah Schmidt
Clinical Neurophysiologist, Charité University Hospital, Berlin
Dr. Schmidt's session on nerve conduction studies demonstrates how electrophysiological patterns distinguish CMT subtypes in routine practice.
Dr. Vikram Nair
Associate Professor, Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Delhi
Dr. Nair coordinates multidisciplinary care approaches, emphasizing teamwork between neurologists, physiotherapists, and occupational therapists.
Hear from speakers shaping CMT and HN care
Our faculty brings decades of combined clinical experience and active research across genetics, biomarkers, and gene-based therapies to the 2026 summit.
8+
Sessions planned
Covering the full arc from epidemiology to targeted therapies over two days.
7
Core topics covered
Genetics, biomarkers, clinical insights, rehabilitation, and gene-based care.
2
Days of learning
An intensive 21-22 November 2026 program in Bengaluru.
1
Shared mission
Advancing knowledge and improving lives in CMT and hereditary neuropathy.
Eight sessions, one clear agenda.
From epidemiology to gene-based therapies, the 2026 summit translates the latest evidence into clinical direction. Here is what attending faculty bring to Bengaluru.
The session on genetic classification gives us a shared language. That matters when a diagnosis changes a family's future.
Dr. Meera Krishnan
Neurologist, Bengaluru
What stands out is the practical focus. The rehabilitation track moves from research to what we can actually use in outpatient care.
Dr. Arjun Nair
Paediatric Neurologist
A two-day agenda that covers the full arc of CMT and HN care, from bedside assessment to emerging targeted therapies.
Dr. Sophie Turner
Clinical Geneticist, UK
The evening lecture on gene therapy is timely. It connects progress in other neuromuscular diseases to our own work.
Dr. Ravi Deshpande
Research Fellow
The best talks happen between sessions
The real payoff of a medical meeting is the corridor conversation. Join colleagues in Bengaluru and leave with new collaborators, not just new slides.